Compile Data Set for Download or QSAR
maximum 50k data
Found 25 of ic50 for UniProtKB: P04233
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182092(4-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(triflu...)
Affinity DataIC50:  410nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182108(1-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,...)
Affinity DataIC50:  750nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182102(4-(1-(3-(5-acetyl-3-(4-(trifluoromethyl)phenyl)-4,...)
Affinity DataIC50:  810nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182104(4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,...)
Affinity DataIC50:  900nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182115(1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(triflu...)
Affinity DataIC50:  930nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182110(4-(1-(3-(5-(methylsulfonyl)-3-(4-(trifluoromethyl)...)
Affinity DataIC50:  950nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182113(6-chloro-1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(...)
Affinity DataIC50:  980nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182095(1-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,...)
Affinity DataIC50:  1.10E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182087(4-(1-(3-(5-acetyl-3-(4-(trifluoromethyl)phenyl)-4,...)
Affinity DataIC50:  1.10E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182101(1-[4-(6-Chloro-2,2-dioxo-3,4-dihydro-2H-2lambda*6*...)
Affinity DataIC50:  1.30E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182103(6-chloro-4-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(...)
Affinity DataIC50:  1.30E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182098(4-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(triflu...)
Affinity DataIC50:  1.30E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182093(1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(triflu...)
Affinity DataIC50:  1.40E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182097(1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(triflu...)
Affinity DataIC50:  1.40E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182099(1-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,...)
Affinity DataIC50:  1.50E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182105(4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,...)
Affinity DataIC50:  1.60E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182106(4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,...)
Affinity DataIC50:  1.60E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182109(1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(4-(triflu...)
Affinity DataIC50:  1.80E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182118(4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,...)
Affinity DataIC50:  1.80E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182117(6-chloro-1-(1-(2-hydroxy-3-(5-(methylsulfonyl)-3-(...)
Affinity DataIC50:  1.90E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182100(1-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,...)
Affinity DataIC50:  2.00E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182094(5-methyl-4-(1-(3-(5-(methylsulfonyl)-3-(4-(trifluo...)
Affinity DataIC50:  2.00E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182114(4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,...)
Affinity DataIC50:  2.60E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182089(1-[3-(4-Bromo-phenyl)-5-methanesulfonyl-4,5,6,7-te...)
Affinity DataIC50:  2.70E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHLA class II histocompatibility antigen gamma chain(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50182107(4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,...)
Affinity DataIC50:  4.40E+3nMAssay Description:Inhibition of MHC2 invariant chainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed